More US states offering boosters amid fear of winter surge


Washington, Nov 18 | Amid fear of a Covid-19 resurgence in the upcoming winter season, more states in the US have started offering booster doses, according to reports.

California made the first move to expand access when public health officials quietly sent a letter to local health jurisdictions and vaccine providers on November 9 instructing them to trust patients to decide whether a booster is appropriate, Xinhua news agency reported on Thursday.

Within days, officials in Colorado, New Mexico, Arkansas, West Virginia and New York City endorsed boosters for all adults.

“More states and jurisdictions are expected to follow,” The Washington Post said in a report on Tuesday.

“If you’re in doubt and you meet the waiting period, just get a booster. Choose the side of greater protection,” Democratic New Jersey Governor Phil Murphy was quoted as saying on Monday.

“With the holidays coming up, we need as many people boosted as possible. It’s that simple.”

The Food and Drug Administration (FDA) is aiming to authorise booster doses of Pfizer-BioNTech’s coronavirus vaccine for all adults as early as Thursday.

A report in The New York Times said that the “move that would expand the number of Americans eligible for additional shots by tens of millions”.

The Centers for Disease Control and Prevention’s (CDC) independent committee of vaccine experts has scheduled a meeting for Friday to discuss data on the booster dose’s efficacy and safety.

If both the FDA and the CDC sign off this week, they will have acted strikingly quickly, a little more than a week after Pfizer asked for authorization of boosters for everyone 18 and older.

Under that scenario, any adult who received a second dose of the vaccine at least six months earlier would be officially eligible to get a booster as soon as this weekend.

The FDA is reportedly expected to rule without consulting its own expert panel, which has met frequently during the pandemic to review vaccine data and make a recommendation ahead of a regulatory decision.

Source: IANS

Next Story

Share Market Closing Bell: Market ends marginally lower amid volatility

Share Market Closing Bell: Market ends marginally lower amid volatility

Dalal Street witnessed tug of war between bulls and bears as Sensex settled at 54208.53 losing 109 points or 0.20 percent and Nifty ended at 16240.30 with loss of 19 points. Bank nifty closed the session at 34163.70 levels with loss of 138 point after erasing early session gain.

BSE Midcap and BSE Small cap indices turned flat after rising around half a percent each. On the sectorial front, Nifty Pharma and FMCG have contributed a percent each on a closing basis. On the flip side Nifty Realty, Nifty PSE ended with losses of 1.75 percent and 1.73 respectively. In Nifty stocks, TATACONSUM, CIPLA and ADANI PORT were the top gainers while POWERGRID, BPCL and TECHM were the prime laggards.

In the daily chart Nifty has ended with a bearish candle. However 16200 levels are protected throughout the day. Index might face high volatility on weekly expiry day. Riding against the trend may not be beneficial for short term traders. According to volume profile 16100 and 16000 may act as immediate support.

Indicators such as MACD and RSI are still struggling to overcome from oversold zone in the daily time frame. From the time cycle prospect Index would remain highly volatile till 27th May of this month. Bollinger band indicates 16650 would remain strong resistance in coming days. On the other hand, Bank nifty has support at 33400 levels while resistance at 35000 levels.

Om Mehra
Research Associate
Choice Broking

Source: Choice India


Please enter your comment!
Please enter your name here